Intralesional doxorubicin as a useful adjunct in the treatment of localized mycosis fungoides tumors with CD30+ large cell transformation

• Jonathan D. Ho, MBBS, D.Sc, Dip.Dermpath,
• Jason Thomas, MBBS,
• Alicia McNish, MBBS,
• Romario Thomas, MBBS,
• Janelle Welch, MBBS,
• Orchid Dawkins, MBBS,
• Rodane Ruddock, MBBS,
• Stephanie Smith-Matthews, MBBS, MS

Affiliations

Jonathan D. Ho, MBBS, D.Sc, Dip.Dermpath

Section of Dermatology, Department of Medicine, The University of the West Indies, Mona Campus, Jamaica West Indies; Department of Pathology, The University of the West Indies, Mona Campus, Jamaica West Indies; Correspondence to: Jonathan D. Ho, MBBS, DSc, Dip Dermpath, A: Room 13, Department of Pathology, The University of the West Indies, Mona campus, Jamaica West Indies.

Jason Thomas, MBBS

Section of Dermatology, Department of Medicine, The University of the West Indies, Mona Campus, Jamaica West Indies

Alicia McNish, MBBS

Section of Dermatology, Department of Medicine, The University of the West Indies, Mona Campus, Jamaica West Indies

Romario Thomas, MBBS

Section of Dermatology, Department of Medicine, The University of the West Indies, Mona Campus, Jamaica West Indies

Janelle Welch, MBBS

Section of Dermatology, Department of Medicine, The University of the West Indies, Mona Campus, Jamaica West Indies

Orchid Dawkins, MBBS

Section of Dermatology, Department of Medicine, The University of the West Indies, Mona Campus, Jamaica West Indies

Rodane Ruddock, MBBS

Section of Dermatology, Department of Medicine, The University of the West Indies, Mona Campus, Jamaica West Indies

Stephanie Smith-Matthews, MBBS, MS

Section of Dermatology, Department of Medicine, The University of the West Indies, Mona Campus, Jamaica West Indies